Clinical trial phases: what to check in a research claim
Understand the purpose of clinical trial phases and the difference between a study being listed, results being reported, and a drug being approved.
A clinical trial phase describes a stage of research in people. It does not, by itself, tell you whether a study succeeded or whether a medicine is approved. Read the phase together with the trial's purpose, status, and reported results.
Research education · AI-assisted, source-checked editorial content
Updated 2026-10-08 · Next review 2027-01-08
Research education. Not clinically reviewed or personal medical advice. Editorial policy
What do the phase labels mean?
The FDA describes early clinical research as focused on safety and how a drug behaves in people. Later phases examine effectiveness and gather more safety information in larger groups. Research can also continue after approval. Each stage asks questions that should be read in the context of its design.
For a specific study, record the phase exactly as the original record gives it. Do not infer a later phase from an announcement about future plans. Keep planned work, work in progress, and completed work as separate entries in your notes.
Separate the study record from its results
A useful evidence table has one column for the study identifier and status, and another for the source of results. Add a third column for the date you checked each source. This prevents a registration page or a recruitment announcement from being mistaken for a published result.
Read the stated question and the reported outcome together. If the result addresses only part of the question in a headline, record the narrower finding. Keep limitations from the original report with the result instead of moving them into a separate note that is easy to lose.
Check approval as a separate question
The FDA's drug development outline treats clinical research and regulatory review as distinct steps. A reference to clinical research is not a substitute for checking an approval record for the exact drug and use being discussed.
Use a three-line summary: what was studied, what was reported, and what remains unknown. This format helps another reader follow the evidence without treating a phase number as a recommendation. For decisions about care, take the actual sources to a qualified clinician rather than relying on a phase label or a product page.
A phase is context. Results and approval need their own records.